OCTA Insights in CNVM, Morphological Characteristics and Correlation With Structural OCT.
Optical Coherence Tomography Angiography Insights in Choroidal Neovascular Membrane, Morphological Characteristics and Correlation With Structural Optical Coherence Tomography.
1 other identifier
observational
80
0 countries
N/A
Brief Summary
To suggest a novel classification of choroidal neovascular membrane based on optical coherence tomography angiography and to correlate morphological characteristics based on optical coherence tomography with clinical criteria of disease activity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2021
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 12, 2021
CompletedFirst Posted
Study publicly available on registry
September 24, 2021
CompletedStudy Start
First participant enrolled
October 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedSeptember 24, 2021
September 1, 2021
1 year
September 12, 2021
September 14, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Morphological characters of choroidal neovascular membrane
To describe morphological criteria of choroidal neovascular membrane using optical coherence tomography angiography (OCTA).
One year
Secondary Outcomes (1)
Correlation between morphological characters of choroidal neovascular membrane and disease activity
One year
Eligibility Criteria
All patients with choroidal neovascular membrane, naive or previously treated.
You may qualify if:
- Patients with all types of CNV, previously treated or naïve.
You may not qualify if:
- The presence of prominent media opacity.
- Significant cataract.
- Poor fixation.
- Any other factor that interferes with obtaining good-quality OCT/OCTA images.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (4)
Corvi F, Cozzi M, Barbolini E, Nizza D, Belotti M, Staurenghi G, Giani A. COMPARISON BETWEEN SEVERAL OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY DEVICES AND INDOCYANINE GREEN ANGIOGRAPHY OF CHOROIDAL NEOVASCULARIZATION. Retina. 2020 May;40(5):873-880. doi: 10.1097/IAE.0000000000002471.
PMID: 30807517RESULTParravano M, Querques L, Scarinci F, Giorno P, De Geronimo D, Gattegna R, Varano M, Bandello F, Querques G. Optical coherence tomography angiography in treated type 2 neovascularization undergoing monthly anti-VEGF treatment. Acta Ophthalmol. 2017 Aug;95(5):e425-e426. doi: 10.1111/aos.13180. Epub 2016 Aug 6. No abstract available.
PMID: 27496070RESULTGrossniklaus HE, Green WR. Choroidal neovascularization. Am J Ophthalmol. 2004 Mar;137(3):496-503. doi: 10.1016/j.ajo.2003.09.042.
PMID: 15013874RESULTQuerques G, Corvi F, Querques L, Souied EH, Bandello F. Optical Coherence Tomography Angiography of Choroidal Neovascularization Secondary to Pathologic Myopia. Dev Ophthalmol. 2016;56:101-6. doi: 10.1159/000442800. Epub 2016 Mar 15.
PMID: 27023343RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Samir Y Saleh, PhD
Assiut University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
September 12, 2021
First Posted
September 24, 2021
Study Start
October 1, 2021
Primary Completion
October 1, 2022
Study Completion
December 1, 2022
Last Updated
September 24, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share